Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
China Crypto Strategy Expands as Beijing Backs National Blockchain Network
China announced crypto plans for a national blockchain network. The proposal appeared in a policy document from the Communist Part...
Peter Schiff Surprised by Bitcoin’s Strength as Michael Saylor’s Strategy Boosts BTC Holdings to 848,250
Schiff continues to expect further declines, but Strategy’s latest purchases highlight the company’s commitment to Bitcoin as a lo...
Metaplanet plans $328M bond sale to cut Bitcoin-backed debt and buy back shares
Metaplanet's bond strategy aims to optimize its balance sheet, potentially enhancing shareholder value and evolving its financial...
STRC Nearly Hits $100 After Bitcoin Giant Strategy Breaks Buyback Promise
Strategy’s STRC preferred stock closed at $99.88 on Monday, its best finish since May, after the bitcoin treasury giant spent roug...
Strategy spent nearly nine times as much on STRC buybacks as Bitcoin last week
Strategy (formerly MicroStrategy) bought 250 Bitcoin for $21.5 million last week while spending $192.4 million to repurchase its S...
South Korean Lender Jeonbuk Bank to Offer Bitcoin-Backed Loans
Bitcoin Magazine South Korean Lender Jeonbuk Bank to Offer Bitcoin-Backed Loans Jeonbuk Bank has become the first bank in South Ko...